MMP9 and breast carcinoma: Furthermore, this study is the first report to suggest the molecular targets involved in the BHMC mechanism for controlling the invasiveness of MDA-MB-231 human breast cancer cells, whereby treatment of BHMC at 12.5 μM reduced the expression level of β-PIX, MMP-9, and MT1-MMP.